G93.44 Billable / specific Adult-onset leukodystrophy with axonal spheroids
ICD-10-CM G93.44 identifies “Adult-onset leukodystrophy with axonal spheroids” as a billable/specific code in the FY2027 U.S. classification, effective October 1, 2026 through September 30, 2027.
Chapter 6: Diseases of the nervous system
Code-level instructions
Inclusion terms1
Adult-onset leukoencephalopathy with axonal spheroids and pigmented glia
Inherited instructions
Chapters 6 · Diseases of the nervous system (G00-G99)
Excludes 28
- certain conditions originating in the perinatal period (P04-P96)
- certain infectious and parasitic diseases (A00-B99)
- complications of pregnancy, childbirth and the puerperium (O00-O9A)
- congenital malformations, deformations, and chromosomal abnormalities (Q00-Q99)
- endocrine, nutritional and metabolic diseases (E00-E88)
- injury, poisoning and certain other consequences of external causes (S00-T88)
- neoplasms (C00-D49)
- symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00-R94)
G93.4 · Other and unspecified encephalopathy
Official index references
Official index references (1)
Leukoencephalopathy (1)
Official conversion history
Historical assignments from the CDC conversion table support data retrieval. They do not authorize substituting a previous code for the current code.
Release dates 2023-10-01
Previous assignment: G93.49
History
Code history
Latest recorded change · FY2024
ChangedUnchanged
FY2024
Effective from
- Added
Adult-onset leukodystrophy with axonal spheroids
Billable diagnosis code
CDC/NCHS · FY2024All editions (7)
| All editions | Effective from | Code history |
|---|---|---|
| FY2024 | 2023-10-01 | Added |
| FY2024 · 04-01 | 2024-04-01 | No tabular change |
| FY2025 | 2024-10-01 | No tabular change |
| FY2025 · 04-01 | 2025-04-01 | No tabular change |
| FY2026 | 2025-10-01 | No tabular change |
| FY2026 · April | 2026-04-01 | No tabular change |
| FY2027 | 2026-10-01 | No tabular change |
This entry is a complete code in the selected edition. Reference checks do not establish clinical appropriateness or guarantee reimbursement.